Pharmaron Beijing Co., Ltd. Stock price
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.43 CNY | +1.14% | -8.59% | -29.50% |
Mar. 28 | Pharmaron's 2023 Profit, Revenue Rise; Misses Estimates | MT |
Mar. 27 | Pharmaron Beijing Co., Ltd. Proposes Final Dividend for the Financial Year Ended December 31, 2023 | CI |
Sales 2024 * | 12.77B 1.77B | Sales 2025 * | 15.63B 2.16B | Capitalization | 33.02B 4.57B |
---|---|---|---|---|---|
Net income 2024 * | 1.65B 229M | Net income 2025 * | 2.28B 315M | EV / Sales 2024 * | 2.9 x |
Net Debt 2024 * | 4.01B 555M | Net Debt 2025 * | 2.6B 360M | EV / Sales 2025 * | 2.28 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
16.5
x | Employees | - |
Yield 2024 * |
0.96% | Yield 2025 * |
1.26% | Free-Float | 51.02% |
1 day | +1.14% | ||
1 week | -8.59% | ||
Current month | -12.51% | ||
1 month | -9.24% | ||
3 months | -29.60% | ||
6 months | -34.31% | ||
Current year | -29.50% |
Managers | Title | Age | Since |
---|---|---|---|
Bei Zheng
FOU | Founder | 56 | 04-06-30 |
Xiao Qiang Lou
FOU | Founder | 56 | 04-06-30 |
Bo Liang Lou
CEO | Chief Executive Officer | 60 | 04-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwan Hung Tsang
BRD | Director/Board Member | 59 | 19-08-14 |
Bo Liang Lou
CEO | Chief Executive Officer | 60 | 04-06-30 |
Xiao Qiang Lou
FOU | Founder | 56 | 04-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 2 M€ | -16.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 20.43 | +1.14% | 25,189,330 |
24-03-27 | 20.2 | -3.07% | 27,024,240 |
24-03-26 | 20.84 | -1.28% | 25,025,070 |
24-03-25 | 21.11 | -0.75% | 36,097,260 |
24-03-22 | 21.27 | -4.83% | 32,799,270 |
End-of-day quote Shenzhen S.E., March 27, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.50% | 4.57B | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |